KILITCH DRUGS (INDIA)
Back to Balance Sheet
|
KILITCH DRUGS (INDIA) Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-2.88 Cr | ₹-2.56 Cr | ₹-1.98 Cr | ₹-1.51 Cr | ₹-1.28 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of KILITCH DRUGS (INDIA) ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-2.88 Cr |
| Mar2024 | ₹-2.56 Cr |
| Mar2023 | ₹-1.98 Cr |
| Mar2022 | ₹-1.51 Cr |
| Mar2021 | ₹-1.28 Cr |
How is Deferred Tax Assets / Liabilities of KILITCH DRUGS (INDIA) Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-2.88 Cr | Negative | |
| Mar2024 | ₹-2.56 Cr | Negative | |
| Mar2023 | ₹-1.98 Cr | Negative | |
| Mar2022 | ₹-1.51 Cr | Negative | |
| Mar2021 | ₹-1.28 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of KILITCH DRUGS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KILITCH DRUGS (INDIA) | ₹636.1 Cr | -7.5% | 8.7% | -13.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,982.0 Cr | 0.9% | 5.6% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,361.0 Cr | 1.2% | 3.7% | -1.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹164,737.0 Cr | 4.4% | 10.3% | 42.1% | Stock Analytics | |
| CIPLA | ₹115,655.0 Cr | -1.7% | 3.1% | -4.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,573.0 Cr | 0.2% | 5.7% | 6% | Stock Analytics | |
KILITCH DRUGS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KILITCH DRUGS (INDIA) | -7.5% |
8.7% |
-13.6% |
| SENSEX | -0.5% |
3% |
-8.5% |
You may also like the below Video Courses